Medicinal – Page 77

Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: a case report

mycolabadmin

An 80-year-old patient with acute myeloid leukemia developed a serious fungal skin infection caused by Rhizopus oryzae on his lower leg. Doctors treated the infection by repeatedly cleaning out the infected tissue and giving him an antifungal medication called posaconazole for just one week. Despite the short treatment duration due to cost concerns, the patient’s wound gradually healed over four months through continued surgical care, showing that sometimes focused surgical treatment can be as effective as long-term medication.

Candida blankii: The Difficult Capture of a Fungus With Pathogenic Potential

mycolabadmin

Candida blankii is a rare fungal pathogen that is increasingly being found in hospital patients’ bloodstreams and respiratory tracts. The organism is difficult to identify using standard laboratory tests, which can delay diagnosis and treatment. This case report describes two adult patients with C. blankii infections and highlights the challenges in identifying this emerging pathogen and its resistance to common antifungal medications.

Lack of correlation between in vitro and within patient measures of P. aeruginosa biofilms in cystic fibrosis

mycolabadmin

Researchers compared how Pseudomonas aeruginosa bacteria form biofilms (protective clusters) in lung samples from cystic fibrosis patients versus in laboratory culture dishes. They found that the bacteria behave quite differently in the lab compared to in patients’ lungs, suggesting that laboratory tests may not accurately predict how well antibiotics will work in real patients. This highlights the importance of studying bacteria directly from patient samples to better understand how infections actually develop and progress.

Deletion of bZIP Transcription Factor PratfA Reveals Specialized Metabolites Potentially Regulating Stress Response in Penicillium raistrickii

mycolabadmin

Scientists discovered that a protein called PratfA controls the production of protective compounds in a fungus (Penicillium raistrickii) that help it survive stress. By removing this protein, they found two new natural products, including one with an unusual structure. The fungus without PratfA became very sensitive to oxidative stress and couldn’t survive well, showing that this protein is important for both making protective compounds and surviving harsh conditions.

Isolation, identification, and production optimization of natural functional pigments produced by Talaromyces atroroseus LWT-1

mycolabadmin

Researchers isolated a special fungus called Talaromyces atroroseus that produces natural red pigments with cancer-fighting properties. These pigments killed cancer cells in laboratory tests while actually helping normal cells grow, which is an ideal combination for therapeutic potential. By optimizing growing conditions, scientists found they can produce large quantities of these pigments efficiently, offering a safe, natural alternative to synthetic dyes for food and cosmetic products.

Neutral Polysaccharides From Hohenbuehelia serotina With Hypoglycemic Effects in a Type 2 Diabetic Mouse Model

mycolabadmin

Researchers extracted and studied special compounds called polysaccharides from H. serotina mushrooms. They found that these compounds significantly reduced blood sugar levels in mice with type 2 diabetes and also protected the liver. The study shows that mushroom polysaccharides could be a safe, natural alternative to existing diabetes medications with fewer side effects.

First human case of Eidernor doerrieniae colonization in a peritoneal dialysis catheter: A warning from silent contamination

mycolabadmin

A 52-year-old dialysis patient noticed brownish particles inside his peritoneal dialysis catheter. Doctors identified a rare fungus called Eidernor doerrieniae using DNA sequencing, which had never been found in humans before. The catheter was removed and the patient received antifungal medications that successfully eliminated the infection without causing serious complications.

Synergistic potential and apoptosis induction of Bunium persicum essential oil and its pure components, cuminaldehyde and γ-terpinene, in combination with fluconazole on Candida albicans isolates: in vitro and in silico evaluation

mycolabadmin

Researchers studied how Bunium persicum essential oil and two of its active components work together with the antifungal drug fluconazole to fight resistant Candida yeast infections. They found that cuminaldehyde, one of the oil’s main components, was particularly effective when combined with fluconazole and could trigger yeast cell death. These natural compounds could offer a promising new approach to treating fungal infections that have become resistant to standard medications.

A Case Report of Candidiasis Cellulitis in Long-Term Corticosteroid Use

mycolabadmin

A 54-year-old man developed a serious skin infection on his hand caused by Candida, a normally harmless fungus, because he had been taking corticosteroid injections for 15 years for breathing problems. Despite antibiotic treatment, the swelling and pain continued. Doctors discovered it was a fungal infection through lab tests and treated it with antifungal medication (fluconazole) after draining the infection, which completely healed within two weeks.

Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I

mycolabadmin

Researchers used advanced chemical analysis to identify different compounds produced by a dangerous fungus called Candida auris that can cause serious infections. They compared fungal strains that were resistant to the antifungal drug fluconazole with those that were susceptible, finding that resistant strains produced different metabolites (chemical compounds) than susceptible ones. These findings could help doctors develop better treatments by identifying what makes this fungus resistant to current medications.

Research Topic: Medicinal